Nearly 40% of women in their 40s would delay mammography screening after learning of its downsides

Nearly 40% of women in their 40s would delay the start of regular breast cancer screening after learning about some of the potential downsides.

That’s according to the results of a new national survey, published in the Annals of Internal Medicine [1]. In April, the U.S. Preventive Services Task Force finalized recommendations that women begin undergoing mammography every other year starting at 40 (instead of 50).

Researchers conducted a survey of nearly 500 women between the ages of 39 to 49 with no history of breast cancer or gene mutations. After viewing a decision aid detailing the potential dangers of mammography, many appeared to change their minds.

“There are women in their 40s who would prefer to have mammography at an older age, especially after being informed of the benefits and harms of screening,” lead author Laura D. Scherer, PhD, with the University of Colorado School of Medicine, and colleagues concluded. “Women who wanted to delay screening were at lower breast cancer risk than women who wanted screening at their current age. Many found information about the benefits and harms of mammography surprising.”

Before viewing the decision aid, about 27% of survey participants preferred to delay screening versus beginning at their current age. That’s compared to 38.5% after viewing the aid, which presented details about overdiagnosis risk as a percentage of all screening-detected cancers (12% to 22%). There was no increase in the number of women never wanting to undergo mammography, at 5.4% before viewing the decision aid and 4.3% afterward. About 37.4% of participants found the information about overdiagnosis “surprising,” 27.2% said the same about risk for potential false-positives, and 22.9% related to the benefits of screening.

"These data suggest that many people who want to delay screening are considering the evidence and deciding that, for them, the harms outweigh the benefits at their current age," the authors noted.

Read more, including potential study limitations, in the official journal of the American College of Physicians at the link below.

Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.